GLOBAL ENDOCRINOLOGY: Geographical variation in the profile of RET variants in patients with medullary thyroid cancer: a comprehensive review

RMB Maciel, AL Maia - European Journal of Endocrinology, 2022 - academic.oup.com
Genetic variability in humans is influenced by many factors, such as natural selection,
mutations, genetic drift, and migrations. Molecular epidemiology evaluates the contribution …

5P strategies for management of multiple endocrine Neoplasia Type 2: a paradigm of precision medicine

SY Li, YQ Ding, YL Si, MJ Ye, CM Xu… - Frontiers in …, 2020 - frontiersin.org
Multiple endocrine neoplasia type 2 (MEN2) is a neuroendocrine cancer syndrome
characterized by medullary thyroid carcinoma, in combination or not with …

Multiple endocrine neoplasia syndromes from genetic and epigenetic perspectives

F Khatami, SM Tavangar - Biomarker insights, 2018 - journals.sagepub.com
Multiple endocrine neoplasia (MEN) syndromes are infrequent inherited disorders in which
more than one endocrine glands develop noncancerous (benign) or cancerous (malignant) …

Prophylactic thyroidectomies in MEN2 syndrome: Management and outcomes

V Bussières, S Roy, J Deladoey, É Rousseau… - Journal of Pediatric …, 2018 - Elsevier
Aim of the study The aim of the study was to evaluate the outcomes of prophylactic
thyroidectomies performed in an academic setting in the context of multiple endocrine …

The RET C611Y mutation causes MEN 2A and associated cutaneous lichen amyloidosis

XP Qi, JZ Peng, XW Yang, ZL Cao, XH Yu… - Endocrine …, 2018 - ec.bioscientifica.com
Background Cutaneous lichen amyloidosis (CLA) has been reported in some multiple
endocrine neoplasia type 2A (MEN 2A) families affected by specific germline RET mutations …

The clinical spectrum of multiple endocrine neoplasia type 2A with cutaneous lichen amyloidosis in Ethnic Han Chinese

XP Qi, JQ Zhao, ZL Cao, E Fu, F Li, YH Zhao… - Cancer …, 2018 - Taylor & Francis
This study systematically reviewed previous literatures and analyzed the genotype–
phenotype relationship between the multiple endocrine neoplasia type 2A (MEN 2A) …

Genetic diagnosis of a Chinese multiple endocrine neoplasia type 2A family through whole genome sequencing

ZF Du, PF Li, JQ Zhao, ZL Cao, F Li, JM Ma… - Journal of Biosciences, 2017 - Springer
Approximately 98% of patients with multiple endocrine neoplasia type 2A (MEN 2A) have an
identifiable RET mutation. Prophylactic or early total thyroidectomy or pheochromocytoma …

Risk-reduction surgery in pediatric surgical oncology: A perspective

JA Sandoval, I Fernandez-Pineda… - Journal of Pediatric …, 2016 - Elsevier
Objective A small percentage of pediatric solid cancers arise as a result of clearly identified
inherited predisposition syndromes and nongenetic lesions. Evidence supports preemptive …

Genotype–Phenotype Correlation in Indian Patients with MEN2-Associated Pheochromocytoma and Comparison of Clinico-Pathological Attributes with Apparently …

S Rajan, G Zaidi, G Agarwal, A Mishra, A Agarwal… - World journal of …, 2016 - Springer
Introduction Pheochromocytoma (PCC) manifests in up to 50% of MEN2 patients. We
correlated the clinico-pathological features of MEN2-associated PCC (MEN-PCC) with RET …

[HTML][HTML] 甲状腺髓样癌特异性标志物及相关基因研究

张丽, 焦凯 - 肿瘤防治研究, 2014 - zlfzyj.com
甲状腺髓样癌(medullary thyroid carcinoma, MTC) 属于中等恶性程度的肿瘤.
选取恰当的肿瘤标志物和相关基因对于确诊肿瘤的性质以及采取合适的手术治疗方式有重要的 …